The Use of Mobile Applications for Managing Care Processes During Chemotherapy Treatments: A Systematic Review.
Journal
Cancer nursing
ISSN: 1538-9804
Titre abrégé: Cancer Nurs
Pays: United States
ID NLM: 7805358
Informations de publication
Date de publication:
Historique:
pubmed:
10
5
2020
medline:
26
11
2021
entrez:
9
5
2020
Statut:
ppublish
Résumé
The recent mobile technology advancements, such as the development of applications (apps) for mobile phones and tablets, can assist in the development of low-cost platforms to monitor therapeutic adherence or complications, providing easily accessible information or guidelines in self-care focused on the care recipient. The aim of this study was to gather scientific evidence about the efficacy of the use of mobile apps during chemotherapy treatments. A systematic review of quantitative studies was performed. All articles published until May 31, 2019 were identified in databases MEDLINE, CINAHL Psychology and Behavioral Sciences Collection, and Cochrane Library. A total of 10 quantitative studies were included. A set of metrics was identified that essentially analyze issues related to the devices' functionalities. The metrics associated with engagement and related to behavioral dimensions, associated with the use of/adherence to the mobile app, are predominant. The clinical metrics represent 25 of a total of 53 identified metrics. Beneficial and statistically significant results were identified related to fatigue, self-efficacy, and improvements in reports of complications. Based on the available research, mobile apps are likely to be a useful and acceptable tool to monitor interventions and complications. In addition, mobile apps can help in the self-management of treatment-related complications. Importantly, these apps need to bridge the academic context and clinical practice, by evaluating the impact of the use of mobile apps in patients. The concept of prescribing apps is being addressed to ensure that apps work and have fair privacy and data security policies that address safety requirements.
Sections du résumé
BACKGROUND
The recent mobile technology advancements, such as the development of applications (apps) for mobile phones and tablets, can assist in the development of low-cost platforms to monitor therapeutic adherence or complications, providing easily accessible information or guidelines in self-care focused on the care recipient.
OBJECTIVE
The aim of this study was to gather scientific evidence about the efficacy of the use of mobile apps during chemotherapy treatments.
METHODS
A systematic review of quantitative studies was performed. All articles published until May 31, 2019 were identified in databases MEDLINE, CINAHL Psychology and Behavioral Sciences Collection, and Cochrane Library.
RESULTS
A total of 10 quantitative studies were included. A set of metrics was identified that essentially analyze issues related to the devices' functionalities. The metrics associated with engagement and related to behavioral dimensions, associated with the use of/adherence to the mobile app, are predominant. The clinical metrics represent 25 of a total of 53 identified metrics. Beneficial and statistically significant results were identified related to fatigue, self-efficacy, and improvements in reports of complications.
CONCLUSION
Based on the available research, mobile apps are likely to be a useful and acceptable tool to monitor interventions and complications. In addition, mobile apps can help in the self-management of treatment-related complications. Importantly, these apps need to bridge the academic context and clinical practice, by evaluating the impact of the use of mobile apps in patients.
IMPLICATIONS FOR PRACTICE
The concept of prescribing apps is being addressed to ensure that apps work and have fair privacy and data security policies that address safety requirements.
Identifiants
pubmed: 32384423
pii: 00002820-202111000-00014
doi: 10.1097/NCC.0000000000000823
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
E339-E360Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. 2010;15(pt 1):1–39.
Hamine S, Gerth-Guyette E, Faulx D, et al. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015;17(2):e52.
Lancaster K, Abuzour A, Khaira M, et al. The use and effects of electronic health tools for patient self-monitoring and reporting of outcomes following medication use: systematic review. J Med Internet Res. 2018;20(12):e294.
Pagliari C, Sloan D, Gregor P, et al. What is eHealth (4): a scoping exercise to map the field. J Med Internet Res. 2005;7(1):e9–e.
WHO Global Observatory for eHealth. mHealth New Horizons for Health Through Mobile Technologies. Geneva, Switzerland; 2011. https://www.who.int/goe/publications/ehealth_series_vol3/en/. Accessed March 14, 2020.
Basch E, Artz D, Dulko D, et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol. 2005;23(15):3552–3561.
Berry DL, Blumenstein BA, Halpenny B, et al. Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol. 2011;29(8):1029–1035.
Basch E, Abernethy AP. Supporting clinical practice decisions with real-time patient-reported outcomes. J Clin Oncol. 2011;29(8):954–956.
Yang LY, Manhas DS, Howard AF, et al. Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication. Support Care Cancer. 2018;26(1):41–60.
Barello S, Triberti S, Graffigna G, et al. eHealth for patient engagement: a systematic review. Front Psychol. 2016;6:2013.
Short CE, DeSmet A, Woods C, et al. Measuring engagement in eHealth and mHealth behavior change interventions: viewpoint of methodologies. J Med Internet Res. 2018;20(11):e292.
Warrington L, Absolom K, Conner M, et al. Electronic systems for patients to report and manage side effects of cancer treatment: systematic review. J Med Internet Res. 2019;21(1):e10875.
Skrabal Ross X, Gunn KM, Patterson P, et al. Mobile-based oral chemotherapy adherence-enhancing interventions: scoping review. JMIR mHealth uHealth. 2018;6(12):e11724.
Marcolino MS, Oliveira JAQ, D'Agostino M, et al. The impact of mhealth interventions: systematic review of systematic reviews. JMIR mHealth uHealth. 2018;2(1):e23.
Osborn J, Ajakaiye A, Cooksley T, et al. Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature. Support Care Cancer. 2019;28(3):1469–1479.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.
Armijo-Olivo S, Stiles CR, Hagen NA, et al. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract. 2012;18(1):12–18.
Nouri R, R Niakan Kalhori S, Ghazisaeedi M, Marchand G, Yasini M. Criteria for assessing the quality of mHealth apps: a systematic review. J Am Med Inform Assoc. 2018;25(8):1089–1098.
Graffigna G, Barello S, Bonanomi A, Lozza E. Measuring patient engagement: development and psychometric properties of the patient health engagement (PHE) scale. Front Psychol. 2015;6:274.
Graffigna G, Barello S, Riva G. How to make health information technology effective: the challenge of patient engagement. Arch Phys Med Rehabil. 2013;94(10):2034–2035.
Wakefield BJ, Turvey CL, Nazi KM, et al. Psychometric properties of patient-facing eHealth evaluation measures: systematic review and analysis. J Med Internet Res. 2017;19(10):e346–e.
Weaver A, Young AM, Rowntree J, et al. Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol. 2007;18(11):1887–1892.
Larsen ME, Rowntree J, Young AM, et al. Chemotherapy side-effect management using mobile phones. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5152–5155.
Larsen ME, Farmer A, Weaver A, et al. Mobile health for drug dose optimisation. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:1540–1543.
Min YH, Lee JW, Shin YW, et al. Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study. J Med Internet Res. 2014;16(5):e135–e.
Cheong IY, An SY, Cha WC, et al. Efficacy of mobile health care application and wearable device in improvement of physical performance in colorectal cancer patients undergoing chemotherapy. Clin Colorectal Cancer. 2018;17(2):e353–e362.
Soh JY, Cha WC, Chang DK, et al. Development and validation of a multidisciplinary mobile care system for patients with advanced gastrointestinal cancer: interventional observation study. JMIR mHealth uHealth. 2018;6(5):e115–e.
Kearney N, McCann L, Norrie J, et al. Evaluation of a mobile phone-based, Advanced Symptom Management System (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer. 2009;17(4):437–444.
Egbring M, Far E, Roos M, et al. A mobile app to stabilize daily functional activity of breast Cancer patients in collaboration with the physician: a randomized controlled clinical trial. J Med Internet Res. 2016;18(9):e238–e238.
Furlong E, Darley A, Fox P, et al. Adaptation and implementation of a mobile phone-based remote symptom monitoring system for people with cancer in Europe. JMIR Cancer. 2019;5(1):e10813–e.
Zhu J, Ebert L, Liu X, et al. Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (part 2): multicenter randomized controlled trial. JMIR mHealth uHealth. 2018;6(4):e104.
Fortney JC, Burgess JF Jr., Bosworth HB, et al. A re-conceptualization of access for 21st century healthcare. J Gen Intern Med. 2011;26(suppl 2):639–647.
Azar KM, Koliwad S, Poon T, et al. The Electronic CardioMetabolic Program (eCMP) for patients with cardiometabolic risk: a randomized controlled trial. J Med Internet Res. 2016;18(5):e134.
Badawy SM, Kuhns LM. Economic evaluation of text-messaging and smartphone-based interventions to improve medication adherence in adolescents with chronic health conditions: a systematic review. JMIR mHealth uHealth. 2016;4(4):e121.
Boulos MN, Brewer AC, Karimkhani C, et al. Mobile medical and health apps: state of the art, concerns, regulatory control and certification. Online J public Health Inform. 2014;5(3):229.
Colomer R, Alba E, González-Martin A, et al. Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM). Ann Oncol. 2010;21(2):195–198.
Walton H, Spector A, Tombor I, et al. Measures of fidelity of delivery of, and engagement with, complex, face-to-face health behaviour change interventions: a systematic review of measure quality. Br J Health Psychol. 2017;22(4):872–903.
Sieverink F, Kelders SM, van Gemert-Pijnen JE. Clarifying the concept of adherence to eHealth technology: systematic review on when usage becomes adherence. J Med Internet Res. 2017;19(12):e402.
Ryan C, Bergin M, Wells JS. Theoretical perspectives of adherence to web-based interventions: a scoping review. Int J Behav Med. 2018;25(1):17–29.
Fortier MA, Chung WW, Martinez A, et al. Pain buddy: a novel use of m-health in the management of children's cancer pain. Comput Biol Med. 2016;76:202–214.
Armes J, Harris J, Cheevers K, et al. eSMART survivorship study: examining the effects of eSMART (electronic symptom management using the Advanced Symptom Management System (ASyMS)) on patient outcomes during the year following chemotherapy treatment. Psychooncology. 2017;26:16–17.
Maguire R, McCann L, Young T, et al. The eSMART RCT: comparing electronic Symtpom management using the advanced Advanced Symptom Management System (ASyMS) with standard care for patients during adjuvant chemotherapy. Health Qual Life Outcomes. 2017;15.
Harris J, Armes J, Cheevers K, et al. eSMART: a European RCT evaluating electronic symptom management using the advanced Advanced Symptom Management System (ASyMS) during adjuvant chemotherapy. Psycho-oncology. 2018;27:23.
Tomlinson M, Rotheram-Borus MJ, Swartz L, et al. Scaling up mHealth: where is the evidence?PLoS Med. 2013;10(2):e1001382.
Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of web-based and mobile health interventions. J Med Internet Res. 2011;13(4):e126.
Agarwal S, LeFevre AE, Lee J, et al. Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist. BMJ (Clinical Research Ed). 2016;352:i1174.
Stoyanov SR, Hides L, Kavanagh DJ, et al. Mobile app rating scale: a new tool for assessing the quality of health mobile apps. JMIR mHealth uHealth. 2015;3(1):e27.
Scherer RW, Meerpohl JJ, Pfeifer N, et al. Full publication of results initially presented in abstracts. Cochrane Database Syst Rev. 2018;11.
Callaham ML, Wears RL, Weber EJ, et al. Positive-outcome bias and other limitations in the outcome of research abstracts submitted to a scientific meeting. JAMA. 1998;280(3):254–257.
Milani RV, Bober RM, Lavie CJ. The role of technology in chronic disease care. Prog Cardiovasc Dis. 2016;58(6):579–583.
Subbe CP, Ovretveit J, Quinn N, et al. Digital technology: opportunities and barriers for usage of personal health records in hospital - report from a -workshop of the health informatics unit at the royal -college of physicians. Future Healthc J. 2019;6(1):52–56.
Byambasuren O, Sanders S, Beller E, et al. Prescribable mHealth apps identified from an overview of systematic reviews. NPJ Digital Med. 2018;1(1):12.
Huckvale K, Prieto JT, Tilney M, et al. Unaddressed privacy risks in accredited health and wellness apps: a cross-sectional systematic assessment. BMC Med. 2015;13(1):214.
Torous J, Firth J. The digital placebo effect: mobile mental health meets clinical psychiatry. Lancet Psychiatry. 2016;3(2):100–102.
Kaplan B. Evaluating informatics applications—some alternative approaches: theory, social interactionism, and call for methodological pluralism. Int J Med Inform. 2001;64(1):39–56.
Pluye P, Hong QN. Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. Annu Rev Public Health. 2014;35:29–45.
Van der Meijden MJ, Tange HJ, Troost J, et al. Determinants of success of inpatient clinical information systems: a literature review. J Am Med Inform Assoc. 2003;10(3):235–243.
Craig Lefebvre R, Tada Y, Hilfiker SW, et al. The assessment of user engagement with eHealth content: the eHealth Engagement Scale1. J Comput Mediat Commun. 2010;15(4):666–681.
Pham Q, Wiljer D, Cafazzo JA. Beyond the randomized controlled trial: a review of alternatives in mHealth clinical trial methods. JMIR mHealth uHealth. 2016;4(3):e107.
Mohr DC, Cheung K, Schueller SM, et al. Continuous evaluation of evolving behavioral intervention technologies. Am J Prev Med. 2013;45(4):517–523.
Collins LM, Dziak JJ, Kugler KC, et al. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med. 2014;47(4):498–504.
Collins LM, Murphy SA, Nair VN, et al. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med. 2005;30(1):65–73.
Lei H, Nahum-Shani I, Lynch K, et al. A “SMART” design for building individualized treatment sequences. Annu Rev Clin Psychol. 2012;8:21–48.
Klasnja P, Hekler EB, Shiffman S, et al. Microrandomized trials: an experimental design for developing just-in-time adaptive interventions. Health Psychol. 2015;34s:1220–1228.
Kramer JN, Kunzler F, Mishra V, et al. Investigating intervention components and exploring states of receptivity for a smartphone app to promote physical activity: protocol of a microrandomized trial. JMIR Res Protoc. 2019;8(1):e11540.
Buccheri S, Sarno G, Frobert O, et al. Assessing the nationwide impact of a registry-based randomized clinical trial on cardiovascular practice. Circ Cardiovasc Interv. 2019;12(3):e007381.